Keynote Speaker

Carl June, Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania and a pioneer in CAR-T cell therapy. His landmark work led to the first FDA-approved CAR-T cell therapy for leukemia and lymphoma, and his ongoing research continues to shape the frontier of cellular immunotherapy for cancer and chronic infection. 

Confirmed Speakers

David Artis, Weill Cornell Medicine, New York, NY, United States
Session: Barrier Immunity

Andrew Bowie, Trinity College Dublin, Ireland
Session: Viral Immunity

Clare Bryant, University of Cambridge, United Kingdom
Session: Inflammasome

Christopher Buckley, University of Oxford, United Kingdom
Session: Stromal-leukocyte crosstalk

Doreen Cantrell, University of Dundee, United Kingdom
Session: Next steps in cytokine targeted therapies

Jonathan Cavanagh, University of Glasgow, United Kingdom
Session: Tackling the complexities of Immunemediated inflammatory diseases

Gloria Choi,  Massachusetts Institute of Technology, Cambridge, MA,
United States 
Session: Brain immunology

Jemin Choi, Hanyang University, Seoul, Korea
Session: KAI

Rebecca Coll, Queen’s University Belfast, United Kingdom
Session: Inflammasome

Yanick Crow, University of Edinburgh, United Kingdom
Session: Sensing interferons

Kate Fitzgerald, UMass Chan Medical School, Worcester, MA, United States
Session: Viral Immunity

Awen Gallimore, Cardiff University, United Kingdom
Session: 

Aroon Hingorani, University College London, United Kingdom
Session: Heterogeneity & Multimorbidity

Ian Humphreys, Cardiff University, United Kingdom
Session: Viral Immunity

Christopher Hunter, University of Pennsylvania, Philadelphia, PA, United States
Session: Next steps in cytokine targeted interventions

Brendan Jenkins, The University of Adelaide, Adelaide, SA, Australia
Session: Cancer Immunology

Yuka Kanno, NIAMS, NIH, Bethesda, MD, United States
Session: Cell Fate

Brian Kim, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Session: Heterogeneity & Multimorbidity

Joanne Konkel, The University of Manchester, United Kingdom
Session: Barrier Immunity

Marcin Kortylewski, Duarte Cancer Center, CA, United States
Session: Fine-tuning cytokine signals

Gerhard Krönke, German Rheumatology Research Center (DRFZ), Berlin, Germany
Session: Next steps in cytokine targeted
interventions

Mariola Kurowsha-Stolarska, University of Glasgow, United Kingdom
Session: Cell Fate

Ho-Keun Kwon, Yonsei university college of medicine, Seoul, Korea
Session: KAI

Beatriz León, NIAID, NIH, Bethesda, MD, United States
Session: Allergy

François Leulier, ENS de Lyon, France
Session: Bacterial immunity

Clare Lloyd, Imperial College London, United Kingdom
Session: Tackling the complexities of Immunemediated inflammatory diseases

 

 

Mary-Ellen Lynall, University of Cambridge, United Kingdom
Session: Brain immunology

Seth Masters, Hudson Institute of Medical Research, Clayton, VIC, Australia
Session: Inflammasome

Claudia Mauri, University College London, United Kingdom
Session: Instructing immunometabolism in health and disease

Iain McInnes, University of Glasgow, United Kingdom
Session: Tackling the complexities of Immunemediated inflammatory diseases

James McLaren, Cardiff University, United Kingdom
Session: Bacterial immunity

Rachel McLoughlin, Trinity College Dublin, Ireland
Session: Bacterial immunity

Karen Mossman, McMaster University, Hamilton, OT, Canada
Session: Viral Immunity

Sandra Nicholson, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
Session: Fine-tuning cytokine signals

Luke O’Neill, Trinity College Dublin, Ireland
Session: Instructing immunometabolism in health and disease

John O’Shea, NIAMS, NIH, Bethesda, MD, United States
Session: Next steps in cytokine targeted
interventions

Jamie Orengo, Regeneron Pharmaceutical, United States
Session: Allergy

Jacob Piehler, University Osnabrück, Germany
Session: Sensing interferons

Fiona Powrie, University of Oxford, United Kingdom
Session: Next steps in cytokine targeted
interventions

Anne Puel, Institut Imagine, Paris, France
Session: Sensing interferons

Deepshika Ramanan, SALK, La Jolla, CA, United States
Session: KAI

Naveed Sattar, University of Glasgow, United Kingdom
Session: Heterogeneity & Multimorbidity

Benedict Seddon, University College London, United Kingdom
Session: Fine-tuning cytokine signals

Miguel Soares, Fundação GIMM, Lisbon, Portugal
Session: Instructing immunometabolism in health and disease

Carrie Sokol, Massachusetts General Hospital, Boston, MA, United States
Session: Allergy

Tony Tiganis, Monash University, Melbourne, VIC, Australia
Session: Instructing immunometabolism in health and disease

Stephen Turner, Monash University, Melbourne, VIC, Australia
Session: Cell Fate

Irina Udalova, University of Oxford, United Kingdom
Session: Stromal-leukocyte crosstalk

Hua Yu, Duarte Cancer Center, CA, United States
Session: Cancer Immunology

Nathaniel West, Genentech, United States
Session: Stromal-leukocyte crosstalk